Harvard biomarkers study: A lipid test for new Parkinson’s and Lewy body Dementia therapies
Learn more about our biomarkers study for Parkinson’s Disease Dementia and Dementia with Lewy Bodies!
This author has not written his bio yet.
But we are proud to say that Academic Web Pages contributed 41 entries already.
Learn more about our biomarkers study for Parkinson’s Disease Dementia and Dementia with Lewy Bodies!
Learn more about our Parkinson’s disease biomarkers study!
Noncoding RNAs active in dopamine neurons are a surprising link between genetic risk and Parkinson’s disease.
This risk assessment tool estimates the chance of a person with Parkinson’s disease to develop global cognitive impairment. More information may be found at Cognitive Risk Score Calculator for Parkinson’s Disease
BRAINcode is an encyclopedia of the entire RNA content of dopamine and pyramidal neurons in the human brain.
More information may be found at BRAINcode Project
Dr. Dina Katabi visits the Advanced Center for Parkinson’s Disease Research to present on new innovations in mobile and wireless technology with application to digital health.
Award-winning actor Alan Alda is doing a lot of the right things to treat Parkinson’s disease, a Harvard researcher said on the day the M.A.S.H. star broke the news of his troubling diagnosis.
Learn more about the Parkinson’s disease study specifically targeting the GBA gene!
Dr. Jie Shen and her team describe an essential role of LRRK in the brain during aging that may help shed light on the causes of PD.
Center for Advanced Parkinson Research
capr@bwh.harvard.edu
857.307.5422
Connect • Giving • Lean in
Clinic appointments • Photo Credits
We are grateful for the support of the APDA.